Clinical Trials

6 enrolled 9 charts

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00652899 2017-12-28

Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer

14 enrolled 9 charts

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00871689 2017-12-28

Chemotherapy, Total-Body Irradiation, Donor Natural Killer Cell Infusion, Aldesleukin, and UCB Transplant in Treating Patients With Relapsed or Refractory AML

Other hematologic neoplasm

2 enrolled 13 charts

Congenital Abnormalities, Leukemia, Leukemia, Myeloid, Acute

NCT01106950 2017-12-28

Haploidentical Natural Killer Cells to Treat Refractory or Relapsed Acute Myelogenous Leukemia (AML)

Other hematologic neoplasm

15 enrolled 12 charts

Leukemia, Myeloid, Acute

NCT01464359 2017-12-28

T-Cell Depleted Double UCB for Refractory AML

Other hematologic neoplasm

3 enrolled 9 charts

Leukemia, Myeloid, Acute

NCT00089778 2017-08-01

Vaccine Treatment of Kidney Cancer

11 enrolled 12 charts

Kidney Neoplasms

NCT01271907 2017-08-01

Drosophila-generated CTL

3 enrolled 8 charts

Melanoma, Neoplasms, Skin Neoplasms

NCT02259348 2017-05-30

Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation

LymphoidMyeloidOther hematologic neoplasmSarcoma

12 enrolled 12 charts

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Sarcoma, Myeloid, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

NCT01754376 2017-04-12

Combined BRAF-Targeted Therapy & Immunotherapy for Melanoma

6 enrolled 12 charts

Melanoma, Neoplasm Metastasis

NCT00440973 2016-03-17

Safety Study of Specific Tumor Target Drug Plus Immune System Therapy in Patients With Kidney Cancer

6 enrolled

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00913913 2015-12-01

Bevacizumab, Autologous Tumor/DC Vaccine, IL-2 and IFNα-2b in Metastatic Renal Cell Carcinoma (RCC) Patients

8 enrolled 10 charts

Carcinoma, Renal Cell

NCT00612222 2015-10-28

Anti-MART-1 F5 Cells Plus ALVAC MART-1 Vaccine to Treat Advanced Melanoma

4 enrolled 9 charts

Melanoma, Skin Neoplasms

NCT01160445 2015-10-28

Phase II Study of Aldesleukin (IL-2) Following the Administration of Zanolimumab (Anti-CD4mAb) in Metastatic Melanoma and Metastatic Renal Cancer

DermatologicGenitourinary

9 enrolled 9 charts

Kidney Neoplasms, Melanoma

NCT00004050 2014-07-29

Leuvectin Followed By Surgery in Treating Patients With Stage II or Stage III Prostate Cancer

13 enrolled

Prostatic Neoplasms

NCT00941928 2014-05-22

Haploidentical Natural Killer (NK) Cells With Epratuzumab for Relapsed Acute Lymphoblastic Leukemia (ALL)

LymphoidOther hematologic neoplasm

2 enrolled 3 charts

Leukemia, Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00203866 2013-09-05

Trial of G250 Peptide and IL-2 Following Surgical Resection of Locally Advanced/Metastatic Renal Cell Carcinoma

40 enrolled

Carcinoma, Renal Cell

NCT00303836 2013-06-06

Vaccine Therapy With or Without Interleukin-2 After Chemotherapy and an Autologous White Blood Cell Infusion in Treating Patients With Metastatic Melanoma

58 enrolled

Melanoma

NCT00509496 2013-01-15

Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Anti-gp100:154-162 TCR Gene Engineered Lymphocytes

21 enrolled 11 charts

Melanoma, Skin Neoplasms

NCT00485563 2012-03-08

A Phase II Study of EC17 (Folate-hapten Conjugate) in Patients With Progressive Metastatic Renal Cell Carcinoma

12 enrolled

Carcinoma, Renal Cell, Neoplasm Metastasis, Neoplasms

NCT00176761 2006-09-11

Tumor-Pulsed Dendritic Cells Used as a Tumor Vaccine

27 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT00100737 2006-02-06

Comparing Interleukin-2 (IL-2) Combined With Rituximab (Rituxan) to Rituximab Alone in Subjects With Non-Hodgkin's Lymphoma (NHL)